Christopher Causey, Director at UNITED THERAPEUTICS Corp (UTHR), sold 3,000 shares at $249.68 ($749K) on 2023-12-12, disclosed to the SEC on 2023-12-13.
Seasonal sale ($749k) by Director — this insider has traded UTHR in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| UTHR | SELL | 2026-02-25 | $520K | — | Filing → |
| UTHR | SELL | 2026-01-06 | $510K | — | Filing → |
| UTHR | SELL | 2026-01-05 | $500K | — | Filing → |